Just when you thought there was nothing new to say about Avandia, Time magazine reports — citing deputy FDA commissioner Josh Sharfstein — that the agency is investigating whether Glaxo broke the law by holding back from the FDA data indicating the drug carried an increased risk of heart attacks.
via blogs.wsj.com
1 comment:
If Glaxo withheld any information this would require the FDA to remove Avandia from the market.
Post a Comment